Medical Devices — Aug 17 – Aug 21, 2026 (Wk 34): Medical Device Sector Sees Moderate Risk, Focus on Local Value, Mixed Company Performance

August 21, 2026 · · 7 min read
Weekly theme roundup · Aug 17 – Aug 21, 2026
Covering the 141 Medical Devices stocks in our database — browse every Medical Devices name →

TL;DR — The medical devices sector registered a moderate risk score this week, with a slight decrease from the previous week. Discussions around local value addition in the industry were noted, alongside varied financial updates from individual companies and some investment activity.

Theme risk
39/100 Moderate
▼ -5 vs last week
Median price / model value
0.98×
roughly fairly priced · 141 stocks
Insider tape (CMP-filtered)
0 buys
open-market, routine & 10b5-1 stripped

What moved

  • The medical devices industry in India has been encouraged to increase its focus on local value addition, suggesting a potential shift towards domestic manufacturing and supply chain development within the sector. [The Economic Times]
  • Several medical device companies reported their latest quarterly results, with Haemonetics' performance highlighted in comparison to other specialty stocks in the sector. Teleflex reported a strong Q2 revenue increase, while Victrex's stock traded lower despite a Q3 recovery and year-to-date gains. ConvaTec's stock held steady as its valuation gap and growth outlook were considered, and Steris's stock stabilized following a record investment in c [TradingView] [Ad-hoc-news.de] [Ad-hoc-news.de] [TradingView] [Ad-hoc-news.de]
  • Abbott Laboratories' Q2 performance, which exceeded expectations and included a profit increase, was noted as potentially influencing its investment narrative. [simplywall.st]
  • Investment firms made moves in the sector; RTW INVESTMENTS, LP purchased shares in iRhythm Holdings Inc, and Westport Asset Management Inc. invested in Bio-Rad Laboratories, Inc. [GuruFocus] [MarketBeat]
  • Co-Diagnostics participated in a media event focused on medical devices and innovations, indicating ongoing engagement in industry discussions and advancements. [AOL.com]

The why behind the week

  • The call for local value addition in the medical device industry could lead to changes in manufacturing strategies and supply chain resilience, potentially impacting the operational costs and market access for companies operating in or looking to enter the Indian market. [The Economic Times]
  • Company-specific financial results and investment activities are key drivers for individual stock performance within the medical devices theme. Strong revenue growth or strategic investments can signal business health and future prospects, while stock movements following earnings reports reflect how investors are interpreting current performance and outlooks. [TradingView] [GuruFocus] [simplywall.st] [Ad-hoc-news.de] [Ad-hoc-news.de]
  • The identification of Indian stocks trading below fair value on strong cash flows, or high-growth stocks with discounted PEG ratios, suggests that some companies in the broader market, potentially including medical device firms, may be seen as having strong underlying financial health or growth potential relative to their current valuations. [simplywall.st] [TradingView]
  • The mention of sustainable dividends in some medical stocks indicates that certain companies in the sector are generating consistent profits that allow for regular shareholder returns, which can be a factor for long-term investors. [The Globe and Mail]

📄 Filings that matter (8-Ks, straight from EDGAR)

The macro backdrop

10-yr Treasury 4.65%Expected inflation 2.3%VIX 15.4High-yield spread 2.75%Yield curve (10y–2y) 0.50%Overall market risk 44/100 Elevated
How to read it
  • Credit Spread: tight — credit markets are relaxed, no stress being priced
  • Yield Curve: positively sloped — the normal, healthy shape
  • Vix: calm — the market is complacent, which cuts both ways (little cushion if news turns)

Every theme swims in this tide — judge the week’s moves against it.

📅 On the calendar — and why it matters here

  • Fri Aug 21 — FOMC (Fed rate decision / minutes). the single biggest scheduled market mover — a rate surprise in either direction repriced everything, hardest on rate-sensitive names (growth, REITs, utilities, homebuilders). Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Wed Aug 26 — GDP. the broadest growth read — confirms or breaks the soft-landing thesis. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Wed Aug 26 — PCE inflation (the Fed's gauge). a hot print pushes rate-cut odds out (pressuring long-duration assets); a soft print does the reverse — one of the highest-impact releases. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Tue Sep 1 — JOLTS (job openings). labor-market tightness — a cooling read eases wage-inflation fears. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Fri Sep 4 — Jobs report (payrolls + unemployment). sets the growth-vs-recession narrative — a weak number lifts recession odds (hits cyclicals, consumer, financials); a strong one can paradoxically pressure rates. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.

What to watch next

  • The overall risk score for Medical Devices is 39/100 (Moderate), a decrease of 5 points from last week. This moderate risk level suggests that the sector is not currently experiencing extreme volatility, which can influence investor sentiment and capital allocation decisions within the theme. [SAVNG data]
  • The median price-to-model-value across 141 stocks in the theme is 0.98x. This indicates that, on average, stocks in the medical devices sector are trading close to their estimated fair value, which can inform evaluations of potential over or undervaluation within the group. [SAVNG data]
  • No open-market insider buys were recorded in this theme this week (routine/10b5-1 stripped). The absence of insider buying can sometimes be interpreted as insiders not seeing immediate, significant undervaluation or positive catalysts for their own companies, though it does not preclude future performance. [SAVNG data]
  • The 10-year Treasury yield at 4.65% and expected inflation at 2.34% provide a backdrop for financing costs and the real return on investments. Higher interest rates can increase borrowing costs for medical device companies, potentially impacting their expansion plans and profitability, especially for those reliant on debt financing for R&D or acquisitions. [macro data]
  • The VIX at 15.42 suggests a relatively calm market environment. A lower VIX typically indicates less market fear and uncertainty, which can contribute to a more stable environment for medical device stocks, as investor confidence generally supports equity valuations. [macro data]
  • The Shiller CAPE ratio at 41.79 and market risk at 44/100 indicate broader market valuation and risk levels. A high CAPE ratio suggests that the overall market may be richly valued, which can influence how investors perceive the relative attractiveness and potential for future returns of specific sectors like medical devices. [macro data]

This week’s headlines (sources)

Every claim above cites its source — headlines link to the original outlet; [SAVNG data] marks our own EDGAR-computed figures. Where our sources don’t explain a move, we say so rather than guess. All weekly roundups →

All Medical Devices roundups: 2026-W37 · 2026-W36 · 2026-W35 · 2026-W33 · 2026-W32 · every scope →

SAVNG is an educational research publication, not a Registered Investment Adviser. Everything here is general-circulation information produced by an automated pipeline — the same for every reader — and is not personalized investment advice, an offer, or a recommendation to buy or sell any security. Any performance figure is hypothetical; past performance does not predict future results. Details.

Get next week's roundup automatically

Get these in any reader — no email, no account. Paste a link into Feedly, Inoreader, NetNewsWire, or your browser.